Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson’s Disease

被引:0
|
作者
C. Requejo
J. A. Ruiz-Ortega
H. Cepeda
A. Sharma
H. S. Sharma
A. Ozkizilcik
R. Tian
H. Moessler
L. Ugedo
J. V. Lafuente
机构
[1] University of the Basque Country (UPV/EHU),LaNCE, Department of Neuroscience
[2] University of the Basque Country (UPV/EHU),Department of Pharmacology
[3] Uppsala University,International Experimental CNS Injury & Repair
[4] Uppsala University Hospital,Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine
[5] Uppsala University,Department of Biomedical Engineering
[6] University of Arkansas,Department of Chemistry & Biochemistry
[7] University of Arkansas,Drug Discovery & Develop
[8] Ever Neuro Pharma,Nanoneurosurgery Group
[9] BioCruces Health Research Institute,Faculty of Health Science
[10] Universidad Autónoma de Chile,undefined
来源
Molecular Neurobiology | 2018年 / 55卷
关键词
Parkinson’s disease; 6-OHDA; Preclinical stage; Nanowired cerebrolysin; Enriched environment; Neuroprotection;
D O I
暂无
中图分类号
学科分类号
摘要
Rearing in enriched environment (EE) improves the recuperation in animal models of Parkinson’s disease (PD). Administration of TiO2-nanowired cerebrolysin (CBL) could represent an additional strategy to protect or repair the nigrostriatal system. This study aims to explore morphofunctional and biochemical changes in a preclinical stage of PD testing the synergistic efficiency of combining both strategies, housing in EE, and nanodelivery of CBL. Sprague-Dawley male rats receiving intrastriatally 6-hydroxydopamine after a short evolution time were segregated into CBL group (rats receiving nanowired CBL), EE group (rats housed in EE), CBL + EE group (rats housed in EE and receiving nanowired CBL), and control group (rats without additional treatment). Prodromic stage and treatment effects were characterized by the presence of motor symptoms (amphetamine-induced rotational behavior test). Tyrosine hydroxylase (TH) immunohistochemistry and Western blot (p-Akt/Akt and p-ERK/ERK 1/2 as survival markers and caspase-3 as apoptotic marker) were performed in striatum and SN. A decrease in motor symptoms was shown by rats receiving CBL. EE monitoring cages revealed that rats from CBL + EE group showed more significant number of laps in the wheel than EE group. In SN, CBL + EE group also presented the highest neuronal density. Moreover, p-Akt/Akt and p-ERK/ERK 1/2 ratio was significant higher and caspase-3 expression was lower in CBL + EE group. In conclusion, the combination of CBL and EE provided evidence of neuoprotective-neurorestorative mechanisms by which this combined strategy promoted morphofunctional improvement by activation of survival pathways after dopamine depletion in a preclinical model of PD.
引用
收藏
页码:286 / 299
页数:13
相关论文
共 50 条
  • [1] Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease
    Requejo, C.
    Ruiz-Ortega, J. A.
    Cepeda, H.
    Sharma, A.
    Sharma, H. S.
    Ozkizilcik, A.
    Tian, R.
    Moessler, H.
    Ugedo, L.
    Lafuente, J. V.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (01) : 286 - 299
  • [2] Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease
    Ozkizilcik, Asya
    Sharma, Aruna
    Vicente Lafuente, Jose
    Muresanu, Dafin F.
    Castellani, Rudy J.
    Nozari, Ala
    Tian, Z. Ryan
    Moessler, Herbert
    Sharma, Hari Shanker
    NANONEUROPROTECTION AND NANONEUROTOXICOLOGY, 2019, 245 : 201 - 246
  • [3] A neuroprotective role for cerebrolysin in a rotenone model of Parkinson's disease
    Stoica, R.
    Popescu, B. O.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S137 - S138
  • [4] Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat
    Barneoud, P
    Mazadier, M
    Miquet, JM
    Parmentier, S
    Dubedat, P
    Doble, A
    Boireau, A
    NEUROSCIENCE, 1996, 74 (04) : 971 - 983
  • [5] Lacosamide exhibits neuroprotective effects in a rat model of Parkinson's disease
    Bilal, Burcin
    Kirazlar, Mehmet
    Erdogan, Mumin Alper
    Yigitturk, Gurkan
    Erbas, Oytun
    JOURNAL OF CHEMICAL NEUROANATOMY, 2023, 132
  • [6] Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson's Disease
    Parra, Irving
    Martinez, Isabel
    Vasquez-Celaya, Lizbeth
    Gongora-Alfaro, Jose L. L.
    Tizabi, Yousef
    Mendieta, Liliana
    NEUROTOXICITY RESEARCH, 2023, 41 (02) : 187 - 200
  • [7] Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson’s Disease
    Irving Parra
    Isabel Martínez
    Lizbeth Vásquez-Celaya
    Jose L. Gongora-Alfaro
    Yousef Tizabi
    Liliana Mendieta
    Neurotoxicity Research, 2023, 41 : 187 - 200
  • [8] Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease
    Li, Xiang-Yun
    Mei, Guang-Hai
    Dong, Qiang
    Zhang, Yu
    Guo, Zhuang-Li
    Su, Jing-Jing
    Tang, Yu-Ping
    Jin, Xue-Hong
    Zhou, Hou-Guang
    Huang, Yan-Yan
    PARKINSONS DISEASE, 2015, 2015
  • [9] Neuroprotective Effects of Cranberry Juice Treatment in a Rat Model of Parkinson's Disease
    Witucki, Lukasz
    Kurpik, Monika
    Jakubowski, Hieronim
    Szulc, Michal
    Mikolajczak, Przemyslaw Lukasz
    Jodynis-Liebert, Jadwiga
    Kujawska, Malgorzata
    NUTRIENTS, 2022, 14 (10)
  • [10] Effects of Postnatal Enriched Environment in a Model of Parkinson's Disease in Adult Rats
    Jungling, Adel
    Reglodi, Dora
    Karadi, Zsofia Nozomi
    Horvath, Gabor
    Farkas, Jozsef
    Gaszner, Balazs
    Tamas, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)